To determine whether WBP2 has a specific role in NSCLC, we first detected the expression of WBP2 in lung cancer specimens, and further assessed the association of this expression with the survival and prognosis of patients via immunohistochemistry and immunofluorescence staining. Here, WBP2 is linked to lung carcinoma.